Things are not so agile in the Biotech space...don't know why ANP doesn't apply to TGA in OZ for accelerated program...even at 25mg dose.
Meanwhile, traditional steroids dominate the inflammation market that's worth over $100B per year.
Will Big Pharma even allow ANP to get to market in the US outside of DMD?
Not sure which companies own the corticosteroids products BUT you can bet they'll be protecting their turf.
Things are not so agile in the Biotech space...don't know why...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.001(1.01%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.8¢ | 10.0¢ | $85.75K | 839.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 816255 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 275536 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |